Non-Current Assets

Deferred Tax Assets and Other Non-Current Assets

Gilead Sciences Deferred Tax Assets and Other Non-Current Assets decreased by 6.0% to $4.55B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 17.6%, from $3.87B to $4.55B. Over 5 years (FY 2020 to FY 2025), Deferred Tax Assets and Other Non-Current Assets shows a downward trend with a -3.2% CAGR.

Analysis

StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryLiquidity
SignalContext dependent
VolatilityStable
First reportedQ4 2014
Last reportedQ1 2026May 7, 2026

How to read this metric

An increase generally reflects a growing long-term asset base or deferred tax position, while a decrease suggests asset liquidation or tax benefit utilization.

Detailed definition

This is the aggregate balance of non-current deferred tax assets and other miscellaneous non-current assets not classifi...

Peer comparison

Commonly found in the non-current asset section of balance sheets for large, diversified financial firms.

Metric ID: deferred_tax_assets_other_noncurrent

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$5.55B$4.74B$4.96B$5.13B$4.86B$4.62B$4.80B$4.95B$5.11B$4.20B$4.79B$5.19B$4.77B$5.49B$3.77B$3.87B$4.03B$4.87B$4.85B$4.55B
QoQ Change-14.6%+4.7%+3.3%-5.2%-5.0%+3.9%+3.2%+3.3%-17.9%+14.1%+8.3%-8.1%+15.2%-31.4%+2.7%+4.1%+20.9%-0.6%-6.0%
YoY Change-12.5%-2.6%-3.3%-3.4%+5.2%-9.1%-0.2%+4.8%-6.7%+30.8%-21.3%-25.4%-15.5%-11.3%+28.5%+17.6%
Range$3.77B$5.55B
CAGR-4.1%
Avg YoY Growth-1.5%
Median YoY Growth-3.3%
Current Streak2 quarters decline

Frequently Asked Questions

What is Gilead Sciences's deferred tax assets and other non-current assets?
Gilead Sciences (GILD) reported deferred tax assets and other non-current assets of $4.55B in Q1 2026.
How has Gilead Sciences's deferred tax assets and other non-current assets changed year-over-year?
Gilead Sciences's deferred tax assets and other non-current assets increased by 17.6% year-over-year, from $3.87B to $4.55B.
What is the long-term trend for Gilead Sciences's deferred tax assets and other non-current assets?
Over 5 years (2020 to 2025), Gilead Sciences's deferred tax assets and other non-current assets has grown at a -3.2% compound annual growth rate (CAGR), from $5.71B to $4.85B.
What does deferred tax assets and other non-current assets mean?
The total value of long-term tax assets and other miscellaneous long-term assets.